Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

745 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial.
Koch EAT, Petzold A, Wessely A, Dippel E, Eckstein M, Gesierich A, Gutzmer R, Hassel JC, Knorr H, Kreuzberg N, Leiter U, Loquai C, Meier F, Meissner M, Mohr P, Pföhler C, Rahimi F, Schadendorf D, Schlaak M, Thoms KM, Ugurel S, Utikal J, Weichenthal M, Schuler-Thurner B, Berking C, Heppt MV. Koch EAT, et al. Among authors: eckstein m. Front Med. 2023 Oct;17(5):878-888. doi: 10.1007/s11684-023-0993-y. Epub 2023 Jul 4. Front Med. 2023. PMID: 37432641 Clinical Trial.
Prospective Evaluation of All-lesion Versus Single-lesion Radiotherapy in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors.
Schubert P, Rutzner S, Eckstein M, Frey B, Schweizer C, Haderlein M, Lettmaier S, Semrau S, Gostian AO, Zhou JG, Gaipl US, Fietkau R, Hecht M. Schubert P, et al. Among authors: eckstein m. Front Oncol. 2020 Oct 29;10:576643. doi: 10.3389/fonc.2020.576643. eCollection 2020. Front Oncol. 2020. PMID: 33251140 Free PMC article.
Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
Daunke T, Beckinger S, Rahn S, Krüger S, Heckl S, Schäfer H, Wesch D, Pilarsky C, Eckstein M, Hartmann A, Röcken C, Wandmacher AM, Sebens S. Daunke T, et al. Among authors: eckstein m. Front Immunol. 2023 Jun 28;14:1157397. doi: 10.3389/fimmu.2023.1157397. eCollection 2023. Front Immunol. 2023. PMID: 37449210 Free PMC article.
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral blood.
Donaubauer AJ, Frey B, Weber M, Allner M, Vogl C, Almajali O, Kuczera L, Tamse H, Balk M, Müller S, Eckstein M, Zülch L, Mogge L, Weissmann T, Fietkau R, Kesting M, Iro H, Gaipl US, Hecht M, Gostian AO. Donaubauer AJ, et al. Among authors: eckstein m. Front Oncol. 2024 Sep 13;14:1451035. doi: 10.3389/fonc.2024.1451035. eCollection 2024. Front Oncol. 2024. PMID: 39346733 Free PMC article.
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Semrau S, Gostian AO, Traxdorf M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Hautmann M, Klautke G, Laban S, Brunner T, Tamaskovics B, Frey B, Zhou JG, Geppert CI, Hartmann A, Balermpas P, Budach W, Gaipl U, Iro H, Fietkau R, Hecht M. Semrau S, et al. Among authors: eckstein m. Cancers (Basel). 2021 Apr 19;13(8):1959. doi: 10.3390/cancers13081959. Cancers (Basel). 2021. PMID: 33921668 Free PMC article.
Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring Approach.
Weissmann T, Speer S, Putz F, Lettmaier S, Schubert P, Shariff M, Semrau S, Gostian AO, Traxdorf M, Mueller SK, Eckstein M, Hautmann M, von der Grün J, Haderlein M, Frey B, Gaipl US, Bert C, Iro H, Fietkau R, Hecht M. Weissmann T, et al. Among authors: eckstein m. J Clin Med. 2021 Oct 11;10(20):4653. doi: 10.3390/jcm10204653. J Clin Med. 2021. PMID: 34682782 Free PMC article.
Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
Hellwig K, Ellmann S, Eckstein M, Wiesmueller M, Rutzner S, Semrau S, Frey B, Gaipl US, Gostian AO, Hartmann A, Iro H, Fietkau R, Uder M, Hecht M, Bäuerle T. Hellwig K, et al. Among authors: eckstein m. Front Oncol. 2021 Oct 21;11:734872. doi: 10.3389/fonc.2021.734872. eCollection 2021. Front Oncol. 2021. PMID: 34745957 Free PMC article.
745 results